Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Shenglang Pharmaceutical is a comprehensive pharmaceutical enterprise based in Nanjing, China, specializing in the research, production, and sales of chemical drug preparations and active pharmaceutical ingredients (APIs). The company maintains a strong presence in the domestic market with a product portfolio covering cardiovascular, digestive, and anti-infective therapeutic areas. Its manufacturing facilities are built to national GMP standards, supporting the production of various dosage forms including injections and oral solids. Shenglang Pharmaceutical focuses on both the development of generic drugs and the improvement of existing formulations to enhance patient outcomes. The company is recognized as a high-tech enterprise in Jiangsu Province and continues to expand its reach within the Chinese healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Shenglang Pharmaceutical.